ATE19623T1 - Verfahren zur herstellung von 1-alpha-hydroxy vitamin d oder 1-alpha hydroxy previtamin d derivaten und previtamin d oder tachysteroladdukten mit geeigneten dienophilen. - Google Patents

Verfahren zur herstellung von 1-alpha-hydroxy vitamin d oder 1-alpha hydroxy previtamin d derivaten und previtamin d oder tachysteroladdukten mit geeigneten dienophilen.

Info

Publication number
ATE19623T1
ATE19623T1 AT82200833T AT82200833T ATE19623T1 AT E19623 T1 ATE19623 T1 AT E19623T1 AT 82200833 T AT82200833 T AT 82200833T AT 82200833 T AT82200833 T AT 82200833T AT E19623 T1 ATE19623 T1 AT E19623T1
Authority
AT
Austria
Prior art keywords
alpha
previtamin
hydroxy
tachysteroladduct
dienophils
Prior art date
Application number
AT82200833T
Other languages
English (en)
Inventor
Maurits Vandewalle
Luc J Vanmaele
Clercq Pierre J De
Sebastianus J Halkes
Wilhelmus R M Overbeek
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of ATE19623T1 publication Critical patent/ATE19623T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT82200833T 1981-07-17 1982-07-05 Verfahren zur herstellung von 1-alpha-hydroxy vitamin d oder 1-alpha hydroxy previtamin d derivaten und previtamin d oder tachysteroladdukten mit geeigneten dienophilen. ATE19623T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8103393 1981-07-17
EP82200833A EP0070588B1 (de) 1981-07-17 1982-07-05 Verfahren zur Herstellung von 1-alpha-hydroxy vitamin D oder 1-alpha hydroxy Previtamin D Derivaten und Previtamin D oder Tachysteroladdukten mit geeigneten Dienophilen

Publications (1)

Publication Number Publication Date
ATE19623T1 true ATE19623T1 (de) 1986-05-15

Family

ID=19837798

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82200833T ATE19623T1 (de) 1981-07-17 1982-07-05 Verfahren zur herstellung von 1-alpha-hydroxy vitamin d oder 1-alpha hydroxy previtamin d derivaten und previtamin d oder tachysteroladdukten mit geeigneten dienophilen.

Country Status (9)

Country Link
US (1) US4539153A (de)
EP (1) EP0070588B1 (de)
JP (3) JPS5823660A (de)
AT (1) ATE19623T1 (de)
CA (1) CA1327977C (de)
DE (1) DE3270978D1 (de)
DK (1) DK172151B1 (de)
ES (1) ES513950A0 (de)
IL (1) IL66317A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0402982B1 (de) * 1989-06-15 1994-01-05 Duphar International Research B.V Adduktaldehyd und seine Anwendung in der Herstellung von Vitamin-D-Derivaten
CH681152A5 (de) * 1991-06-04 1993-01-29 Marigen S.A. Neue biotenside und antitumorale ester und phosphatide mit vitamin-d- und vitamin-e-verbindungen, ihre herstellung und aufarbeitung zu spontan dispergierbaren konzentraten.
ES2170069T3 (es) * 1992-06-22 2002-08-01 Bone Care Int Inc 1-alfa-hidroxiprevitamina d para administracion oral.
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
IN188477B (de) * 1998-06-23 2002-09-28 Hoffmann La Roche
CA2481909C (en) * 2002-04-11 2013-07-02 Instytut Farmaceutyczny Preparation of 24-alkyl analogs of cholecalciferol
WO2005067673A2 (en) * 2004-01-06 2005-07-28 The University Of Tennessee Research Foundation Enzymatic method to produce 7-dehydropregnenolone, vitamin d3-like compounds and derivatives thereof
TW200714580A (en) * 2005-10-14 2007-04-16 Formosa Lab Inc Process for preparing vitamin D analogs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901928A (en) * 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US3993675A (en) * 1975-02-24 1976-11-23 Hoffmann-La Roche Inc. Process for the preparation of 1α,25-dihydroxycholecalciferol
US4069321A (en) * 1975-10-14 1978-01-17 Merck & Co., Inc. Blocked cholecalciferol and dihydrotachysterol 3 derivatives
US4022768A (en) * 1976-02-12 1977-05-10 Wisconsin Alumni Research Foundation Process for preparation of 1α,25-dihydroxycholecalciferol
US4110446A (en) * 1977-07-14 1978-08-29 Wisconsin Alumni Research Foundation Method of treating milk fever in dairy cattle with 1,25-dihydroxycholecalciferol
US4202829A (en) * 1978-01-05 1980-05-13 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4206131A (en) * 1978-06-19 1980-06-03 The Upjohn Company Compounds and process
JPS557215A (en) * 1978-06-30 1980-01-19 Teijin Ltd Preparation of active vitamin d3 or its oh-protected derivative and/or its corresponding previtamin d3 or its oh-protected derivative
PH16989A (en) * 1978-11-07 1984-05-04 Res Inst Medicine Chem Process for the preparation of 1-hydroxylated vitamin d compounds
US4335120A (en) * 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials

Also Published As

Publication number Publication date
CA1327977C (en) 1994-03-22
DK172151B1 (da) 1997-12-01
DE3270978D1 (en) 1986-06-12
IL66317A0 (en) 1982-11-30
JPS63107964A (ja) 1988-05-12
US4539153A (en) 1985-09-03
DK315782A (da) 1983-01-18
JPH037664B2 (de) 1991-02-04
JPH0420431B2 (de) 1992-04-02
JPH0339058B2 (de) 1991-06-12
JPS6399053A (ja) 1988-04-30
ES8308847A1 (es) 1983-10-01
JPS5823660A (ja) 1983-02-12
EP0070588B1 (de) 1986-05-07
ES513950A0 (es) 1983-10-01
EP0070588A1 (de) 1983-01-26
IL66317A (en) 1987-07-31

Similar Documents

Publication Publication Date Title
ATE53038T1 (de) Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
AT366400B (de) Verfahren zur herstellung kathodisch abscheidbarer lackbindemittel
AT364835B (de) Verfahren zur herstellung neuer 0-substituierter derivate des (+)-cyanidan-3-ols und ihrer salze
DE3382299D1 (de) Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
ATE19623T1 (de) Verfahren zur herstellung von 1-alpha-hydroxy vitamin d oder 1-alpha hydroxy previtamin d derivaten und previtamin d oder tachysteroladdukten mit geeigneten dienophilen.
AT372390B (de) Verfahren zur herstellung von neuen 4'-jodderivaten von anthracyclinglykosiden
AT383123B (de) Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat
DK408186A (da) Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne
DE3884870T2 (de) Verfahren zur Herstellung von Vitamin-D-Derivaten.
PT77172A (de) Verfahren zur herstellung von rhamnose oder fucose
DE3679947D1 (de) Halbleiteranordnungen und verfahren zur herstellung mittels ionenimplantation.
DE3161243D1 (en) 22-arylsulfonyl-24,25-dihydroxycholestanes and process for preparing the same
ATA498280A (de) Verfahren zur stereospezifischen herstellung von d-carbamylderivaten von alpha-hydroxysaeuren
ATA221580A (de) Verfahren zur herstellung von isopropylamino-pyrimidin-hydroxyderivaten
JPS5566512A (en) Method and composition for treating difficulties by administration of choline or choline dissociating compound
JPS5268196A (en) Bicyclomycin derivatives
JPS523091A (en) A prcess for preparing cephalosporins
ATA333379A (de) Verfahren zur herstellung neuer derivate des(1, 3)-benzodioxins
DE3069793D1 (en) Method for the introduction of an oxygen-containing functional group into ansamycines, compounds thus obtained, and pharmaceutical compositions containing them
IT1054324B (it) Metodo per la purificazione di acque di scarico contenenti composti organici di carattere anionico mezzi adatti allo scopo e procedimento per la loro preparazione
ATA611879A (de) Verfahren zur herstellung fester arzneiformen
PT74359A (de) Verfahren zur herstellung neuer clavam-derivate
HUT37739A (en) New process for producing 2-aroyl-phenylacetone-derivatives
ATE33828T1 (de) Verfahren zur herstellung von 1-hydroxylierten vitamin d derivaten.
JPS5236628A (en) Process for preparation of novel organophosphorus compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee